| Identification | Back Directory | [Name]
1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4 -oxo-quinoline-3-carboxylic acid | [CAS]
354812-41-2 | [Synonyms]
DL-Moxifloxacin
N-Methyl Moxifloxacin HCl
N- methyl moxifloxacin hydrochloride
1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4 -oxo-quinoline-3-carboxylic acid
7-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylicaci
7-(1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo- | [Molecular Formula]
C21H24FN3O4 | [MOL File]
354812-41-2.mol | [Molecular Weight]
401.43 |
| Hazard Information | Back Directory | [Uses]
1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid can be used as an intermediate in organic synthesis and Pharmaceutical intermediates, mainly used in laboratory research and development processes and chemical production processes. | [Synthesis]
 1.Load a mixture of corresponding acid derivative (3.5 mmol) with piperazine (5.25mmol) in a small flask fitted with a micro condenser, placed in the microwave reactor.2. Irradiate the reaction mixture for 25 minutes at 150°C under solvent free conditions.
|
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|